Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Jitao Guo"'
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0302432 (2024)
Digital transformation, as a significant shift in optimizing enterprise resource allocation and enhancing information connectivity, offers the opportunity to stimulate the endogenous dynamics of corporate green governance. Employing a sample of 3,002
Externí odkaz:
https://doaj.org/article/47c3461cdab74a2e843dc0589d5d8b4d
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Adoptively transferred T cell-based cancer therapies have shown incredible promise in treatment of various cancers. So far therapeutic strategies using T cells have focused on manipulation of the antigen-recognition machinery itself, such as through
Externí odkaz:
https://doaj.org/article/274df8cd999a4b4397d1affc1b467665
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/9c433c113f8e4b62b9f54d86a7325dd1
Autor:
Tanyu Hu, Krung Phiwpan, Jitao Guo, Wei Zhang, Jie Guo, Zhongmei Zhang, Mangge Zou, Xuejie Zhang, Jianhua Zhang, Xuyu Zhou
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0158432 (2016)
Wnt/β-catenin signaling pathway plays essential roles in mammalian development and tissue homeostasis. MicroRNAs (miRNAs) are a class of regulators involved in modulating this pathway. In this study, we screened miRNAs regulating Wnt/β-catenin sign
Externí odkaz:
https://doaj.org/article/65483ee34dfc4e9dad3ccda571949fa5
Publikováno v:
Scientific and Social Research. 5:36-43
This paper takes the development department of Nanjing Agricultural University as the research object for organization management research. Using organizational culture and values as the driving force, and based on the establishment model of employer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9a22932d6eb16de9ba90b9eb949de5c
https://doi.org/10.26689/ssr.v5i1.4728
https://doi.org/10.26689/ssr.v5i1.4728
Monocyte-derived dendritic cell (moDC)–based cancer therapies intended to elicit antitumor T-cell responses have limited efficacy in most clinical trials. However, potent and sustained antitumor activity in a limited number of patients highlights t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2741dbf2856acd0e201c55b1f3094ad1
https://doi.org/10.1158/2326-6066.c.6549918.v1
https://doi.org/10.1158/2326-6066.c.6549918.v1
Supplementary Data Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a586d93812c163cc7a284aee1fe069c0
https://doi.org/10.1158/2326-6066.22542423.v1
https://doi.org/10.1158/2326-6066.22542423.v1
Supplementary Data Fig 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eeb1d6fc747e5d6c53fecb8b0e264e1
https://doi.org/10.1158/2326-6066.22542429
https://doi.org/10.1158/2326-6066.22542429
Supplementary Data Fig 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a242279169eaabc62394d4e8ffafecd
https://doi.org/10.1158/2326-6066.22542426
https://doi.org/10.1158/2326-6066.22542426
Autor:
Eduardo Davila, Cruz Velasco Gonzales, Yuji Zhang, Kenisha Younger, Jackline Joy Lasola, Alexander K Tsai, Jitao Guo, Ann Mary Joseph, Sabina Kaczanowska
T cell–based immunotherapies are a promising approach for patients with advanced cancers. However, various obstacles limit T-cell efficacy, including suboptimal T-cell receptor (TCR) activation and an immunosuppressive tumor environment. Here, we d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193ea8dedfc00e4647b1dd8edb28aebc
https://doi.org/10.1158/0008-5472.c.6509513
https://doi.org/10.1158/0008-5472.c.6509513